ERKä¿¡å·é€šè·¯å’ŒPI3-Kä¿¡å·é€šè·¯æ˜¯Survivin的上游激活分åä¿¡å·é€šè·¯,并且DADLE还通过å‡å°‘活性氧(ROS)的产生,阻æ¢çº¿ç²’体跨膜电ä½â–³(?)mt的下é™,促进Bcl-2åŸºå› çš„è½¬å½•å’Œè¡¨è¾¾å’ŒæŠ‘åˆ¶Bax蛋白从胞浆到线粒体的转ä½,呿Œ¥äº†å¯¹å¿ƒè‚Œç»†èƒžçš„ä¿æŠ¤ä½œç”¨ã€‚Activation of opioid receptors has been shown to be cardioprotective. Although activation of opioid receptors has been shown to regulate infarct size in kinds of cardiomyocytes its signal pathway in neonatal cardiomyocytes apoptosis remains elusive. Survivin is known to be essential for cell division and acts as an inhibitor of apoptosis during embryonic development and in adult cancerous tissues. However, the cardiovascular role of survivin is unknown. The present study aimed to investigate the role of survivin in the antiapoptotic effect ofδ-opioid receptor activation in cultured cardiomyocytes from neonatal rats. Cardiomyocyte apoptosis, as assessed by TdT-mediated dUTP nick end labeling, Hoechst 33258 staining and DNA ladder formation, was induced by serum/glucose deprivation (DEPV). mRNA transcripts of survivin and Bcl-2 were measured by quantitative real time polymerase chain reaction. Translocation of Bax from cytosol to mitochondria was determined by detection of the differential distribution of the protein in cytosol and in mitochondria. Protein levels of survivin, Bcl-2 and Bax were assessed by Western blot analysis. The levels of survivin, Bcl-2 and extracellular signal-regulated kinase (ERK) was positively correlated with the antiapoptotic action of a d-opioid receptor agonist, [D-Ala2, D-Leu5] -enkephalin acetate salt (DADLE). Whilst Bax translocation was inversely correlated with the changes of survivin and Bcl-2.Survivin RNA interference (RNAi) increased DEPV-induced cardiomyocyte apoptosis. Moreover, the antiapoptotic effect of DADLE was blunted by survivin RNAi. Inhibition of ERK prevented DADLE-induced decrease in apoptosis and Bax translocation, and increase in survivin and Bcl-2.DADLE-induced increase in survivin was also blunted by phosphoinositol 3-kinase (PI3-K) inhibition. In conclusion, survivin mediates the antiapoptotic effect ofδ-opioid receptor activation in cardiomyocytes. ERK and PI3-K are upstream regulators of survivin. Bcl-2 expression and Bax translocation are associated with this antiapoptotic action. å†…æºæ€§çš„硫化氢(H2S)被誉为是继一氧化氮(NO)和一氧化碳(CO)之åŽçš„第三ç§é‡è¦çš„æ°”体信å·åˆ†å,它具有é‡è¦çš„ç”Ÿç†æ„义,在心血管系统,å®ƒæœ‰èˆ’å¼ è¡€ç®¡é™ä½Žè¡€åŽ‹,抑制血管平滑肌细胞增殖å‡è½»è¡€ç®¡é‡æž„以åŠå‡å°ç¼ºè¡€å†çŒæ³¨æ—¶çš„心肌梗æ»é¢ç§¯ç‰å¤šç§ç”Ÿç‰©å¦æ•ˆåº”。但其对缺血缺氧引å‘çš„å¿ƒè‚Œç»†èƒžçš„å‡‹äº¡æ˜¯å¦æœ‰ç›´æŽ¥ä½œç”¨è‡³ä»Šè¿˜æœªè§æŠ¥é“ã€‚æˆ‘ä»¬ç”¨åŽŸä»£åŸ¹å…»çš„æ–°ç”Ÿå¤§é¼ å¿ƒè‚Œç»†èƒžç ”ç©¶H2S对心肌细胞的直接作用åŠå…¶åˆ†åä¿¡å·æœºåˆ¶,å‘çŽ°ç”Ÿç†æµ“度下的NaHS预处ç†å¿ƒè‚Œç»†èƒžèƒ½å¤ŸæŠ‘制缺氧/夿°§å¼•å‘çš„å¿ƒè‚Œç»†èƒžèƒ½å¤Ÿå¢žåŠ Survivinå’ŒBcl-2表达,抑制Caspase3çš„å…³ç³»æ˜¯æ€Žæ ·æ˜¯æˆ‘ä»¬ä¸‹ä¸€æ¥è¦è§£å†³çš„问题。我们首次å‘现GSK3β的活性在NaHS抗心肌细胞凋亡ä¸å‘挥é‡è¦ä½œç”¨,但是其作用机制如Survivin的表达是å¦å—到GSK3β的活性的影å“,GSK3Î²çš„ä¸Šæ¸¸è°ƒæŽ§åˆ†åæ˜¯ä»€ä¹ˆ,GSK3β通路与MAPKé€šè·¯é—´æ˜¯å¦æœ‰ä¸²è¯ç‰è¿˜æœ‰å¾…进一æ¥çš„ç ”ç©¶ã€‚Endogenous hydrogen sulfide (H2S) is the third gaseous signaling molecule which discovered recently, having significant physiological functions. Injection of NaHS has been shown to regulate infarct size and decreased the duration and severity of ischemia/reperfusion-induced arrhythmias in the isolated heart while increasing cell viability in cardiac myocytes, its signal pathway in neonatal cardiomyocytes apoptosis remains elusive.The present study aimed to investigate the role of survivin in the antiapoptotic effect of H2S preconditioning in cultured cardiomyocytes from neonatal rats. NaHS preconditioning decreased the ischemia/reperfusion-induced apoptosis both in vivo and in vitro. H2S preconditioning increases survivin and Bcl-2 expression and GSK3(?) phosphorylation, while inhibits the activation of Caspase3 precursor. Survivin mediates the antiapoptotic effect of H2S preconditioning in cardiomyocytes. The upstream regulators of GSK3(?) and the crosstalk between survivin, Bcl-2 and Caspase3 precursor need to be further investigation.æ–‡ä¸æ‰€ç”¨è‹±æ–‡ç¼©å†™åŠä¸è‹±æ–‡å¯¹ç…§3βWild type GSK3-βS9A GSK3-βS9A MutantR96A GSK3-βR96A MutantIPC缺血预适应(ischemia preconditioning)ERK细胞外信å·è°ƒèŠ‚æ¿€é…¶(extracellular signal-regulated kinase)ROS活性氧(reactive oxygen species)RNAi RNA干扰(RNA interference)PI3-K磷脂酰肌醇-3-激酶(phosphoinositol 3-kinase)TUNELè„±æ°§æ ¸ç³–æ ¸è‹·é…¸æœ«ç«¯è½¬ç§»é…¶ä»‹å¯¼çš„ç¼ºå£æœ«ç«¯æ ‡è®°æ³•(terminal-deoxynucleotidyl transferase mediated nick end labeling)IS/ RE Ischemia/ Reperfusion缺血/å†çŒæ³¨PBS磷酸ç›ç¼“冲液(phosphote buffered saline)AKT PI3-K controlled serine/threonine kinaseGFP绿色è§å…‰è›‹ç™½(green fluorescent protein)PCR多èšé…¶é“¾å应(polymerase chain reaction)... |